rs730880817
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PS4_SupportingPP1_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000257.4(MYH7):c.5399C>T (p.Ala1800Val) variant has been identified in 2 individuals with DCM (PS4_Supporting; GeneDx pers. comm.; LMM pers. comm.) and segregated with DCM in 6 affected relatives from 1 family (PP1_Moderate; GeneDx pers. comm.). This variant was absent from large population studies (PM2; gnomAD v2.1.1, http://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis did not provide evidence for or against an impact to the protein. In summary, due to insufficient evidence, this variant is classified as uncertain significance for dilated cardiomyopathy (DCM) in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (Kelly 2018 PMID:29300372): PS4_Supporting, PP1_Moderate, PM2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA016070/MONDO:0005021/002
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.5399C>T | p.Ala1800Val | missense_variant | 37/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.5399C>T | p.Ala1800Val | missense_variant | 36/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.5399C>T | p.Ala1800Val | missense_variant | 37/40 | 1 | NM_000257.4 | ENSP00000347507.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Nov 16, 2012 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. We classify it as likely disease causing, and suitable for predictive testing of at-risk family members. This is a novel variant. This is a conservative amino acid change. The Alanine at position 1800 is conserved throughout evolution. Other variants have been reported in association with disease at nearby codons according to HGMD: p.Asp1792Gly (Waldmuller et al 2011; associated with dilated cardiomyopathy), p.Leu1793Pro (Dye et al 2006, Uro-Coste et al 2009; reported in a case of myosin storage myopathy), p.Gln1794Glu (Lakdawala et al 2012; dilated cardiomyopathy); Glu1801Gly (Waldmuller et al. 2011; dilated cardiomyopathy), p.Gly1808Ser (Marsiglia et al 2013; hypertrophic cardiomyopathy), and p.Gly1808Ala (Hershberger et al 2008; dilated cardiomypathy). In silico analysis with PolyPhen2 predicts the variant to be probably damaging. In total this variant has apparently been seen in at least 4 individuals in this family with some sort of cardiomyopathy phenotype including Elijah, his mother (an obligate carrier), his grandfather, and the half-uncle who had a cardiac arrest at the age of seven. Thus we have moderate segregation data in this family. The variant has not been seen in >6700 individuals including GeneDx controls and individuals from population databases. GeneDx did not see this variant in a sample of 289 control individuals of different ethnic backgrounds (unclear how many match the patient’s African American ancestry). The variant is not currently listed in the NHLBI Exome Sequencing Project dataset, which includes variant calls on ~6500 Caucasian and African American individuals (as of January, 2014). About 2200 individuals match the patient’s ancestry. The variant is not listed in 1000 Genomes. Based on these data we would consider this variant likely disease causing. The segregation data and absence in >2200 ancestry-matched individuals does support pathogenicity. Further segregation data in the patient's other affected relatives could strengthen confidence in the pathogenicity. The patient’s mother reports that some of her other affected half-sibs have already been tested but we don't have that data. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 30, 2021 | Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in ClinVar (ClinVar Variant ID#181279; Landrum et al., 2016) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 28, 2015 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ala1800Va l variant in MYH7 has not been previously reported in individuals with cardiomyo pathy or in large population studies. Alanine (Ala) at position 1800 is highly c onserved in evolution and the change to valine (Val) was predicted to be pathoge nic using a computational tool clinically validated by our laboratory. This tool 's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011 ). In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Ala1800Val variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at